Palestine Lung Cancer Newswire

Get by Email • RSS

No articles found

30 days 00:07:04

Featured Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 08:00 GMT

Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla™ EGFR Mutation Test

PRESS RELEASE 02/06/2025, 10:00 CEST Biocartis Announces IVDR Class C CDx Certification of the Idylla™ EGFR Mutation Test Mechelen, Belgium, 02 June 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce that …

Distribution channels: Technology ...
Published on June 2, 2025 - 00:00 GMT

HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting

— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study — — Webcast to be held at 8:30 am HKT on Tuesday, June 3 to discuss the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on May 31, 2025 - 18:46 GMT

Quitting tobacco? Here are five facts to help you

May 31 is World No Tobacco Day. If you’ve tried to stop using tobacco before and then started again, don’t be discouraged! You can use this observance to start creating a plan for how to stop, which will greatly increase your chances of quitting for good. …

Distribution channels:
Published on May 31, 2025 - 12:04 GMT

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell ...

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on May 31, 2025 - 12:00 GMT

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 31, 2025 - 12:00 GMT

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 31, 2025 - 12:00 GMT

ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025

– Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) – – Padeliporfin VTP treatment continues to be safe and well-tolerated, …

Distribution channels: Technology ...
Published on May 30, 2025 - 11:39 GMT

In-Depth Analysis Of The Global Sarcoidosis Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034

The Business Research Company’s Sarcoidosis Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /⁨EINPresswire.com⁩/ -- What Is The Forecasted Growth Of The Sarcoidosis …

Distribution channels: Business & Economy, Chemical Industry ...

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 818,213,795 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 09:30 GMT

Dr. Ushma Kakkad Earns Certification in Conscious Sedation with Nitrous Oxide from IDA

Certification empowers Dr. Kakkad to offer anxiety-free dental care using nitrous oxide for kids and adults at Summirow Dental Hospital. SURAT, GUJARAT, INDIA, June 2, 2025 /⁨EINPresswire.com⁩/ -- Introduction We’re proud to share some exciting …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 08:08 GMT

Bracane Company Earns Ecovadis Silver Medal for Sustainability Excellence

Ranked Among Top 15% of Companies Globally, Underscoring Bracane’s Commitment to Environmental Stewardship, Social Responsibility, and Ethical Governance PLANO, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Bracane Company, Inc., a …

Distribution channels: Education, Energy Industry ...
Published on June 2, 2025 - 07:49 GMT

MOIN Launches Cross-Border Remittance Service via Toss App, Enhancing Accessibility for 28 Million Users

MOIN, a leading fintech company specializing in cross-border remittance solutions, has launched its cross-border money transfer service on Toss SEOUL, EUNPYEONG, SOUTH KOREA, June 2, 2025 /⁨EINPresswire.com⁩/ -- MOIN, a leading fintech company …

Distribution channels: Amusement, Gaming & Casino, Automotive Industry ...
Published on June 2, 2025 - 06:51 GMT

Narconon Arrowhead Hosts Celebration for Graduate's 25 Years of Sobriety

CANADIAN, OK, UNITED STATES, June 1, 2025 /⁨EINPresswire.com⁩/ -- The Narconon Arrowhead Drug and Alcohol Rehabilitation Program recently hosted a special celebration as Bobby Newman, a program graduate, marked 25 years of sobriety. Newman, who …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on June 1, 2025 - 23:16 GMT

Luis M. Gallardo Launches the Meta Pets Method, A Playful Path to Transformation for Therapists, Coaches, and Educators

A Card-Based System for Self-Inquiry, Healing, and Awakening in Education, Coaching, and Therapy. MIAMI, FL, UNITED STATES, June 1, 2025 /⁨EINPresswire.com⁩/ -- Author, hypnotherapist, and global well-being advocate Luis Miguel Gallardo announces …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 1, 2025 - 23:00 GMT

Impelsys Strengthens AI Transformation Strategy with AlgoShack Partnership

NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Impelsys, a global leader in technology solutions, is pleased to announce its strategic partnership with AlgoShack, a company that offers algoQA—a unified platform for end-to-end …

Distribution channels: Book Publishing Industry, Education ...
Published on June 2, 2025 - 05:00 GMT

Communiqué de presse : Sanofi acquiert Blueprint Medicines, enrichit son portefeuille dans les maladies immunologiques ...

Sanofi acquiert Blueprint Medicines, enrichit son portefeuille dans les maladies immunologiques rares et ajoute un pipeline d’immunologie de stade précoce Le portefeuille de Sanofi s’enrichit du seul médicament approuvé, en croissance rapide, pour la …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 05:00 GMT

Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short ...

Press release – No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome Copenhagen, Denmark, June 2, 2025 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”) ( …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 05:00 GMT

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-...

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology Adds fast-growing and only approved medicine for advanced and indolent systemic mastocytosis to the Sanofi portfolio …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 05:00 GMT

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options ...

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 02:29 GMT

Colorado public health officials release additional locations for potential measles exposures

The DEN airport case has resulted in three additional confirmed cases of measles Denver (June 1, 2025) — The Colorado Department of Public Health and Environment and El Paso County Public Health have confirmed measles in two adult unvaccinated El Paso …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 2, 2025 - 02:06 GMT

Volunteers support the NHS for 6 million hours this year

Tens of thousands of people have volunteered to help the NHS over the last year, according to new figures. From people in their late teens to those in their late eights volunteers have helped with tasks such as directing loved ones around hospitals, …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on June 2, 2025 - 00:00 GMT

HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting

— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI Phase III China study — — Webcast to be held at 8:30 am HKT on Tuesday, June 3 to discuss the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 23:30 GMT

Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Company (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 1, 2025 - 23:26 GMT

TORRAS Personal Cooling with Coolify Series: A Tech-Driven Solution for Comfort, Wellness, and Women's Health

LOS ANGELES, June 01, 2025 (GLOBE NEWSWIRE) -- As global temperatures continue to rise and daily comfort becomes a growing concern, TORRAS is making waves with its innovative Coolify series—a wearable air conditioner engineered to deliver rapid, personal …

Distribution channels:
Published on June 1, 2025 - 23:00 GMT

Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in ...

– New Drug Application based on positive results from the Phase 2 KOMET-001 trial – – FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 – – Potential first approval of a menin inhibitor for the treatment of adult …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 05:21 GMT

Smile Scarsdale Family Dental Celebrates One Year of Smiles as Trusted Family Dentist in Scarsdale

SCARSDALE, NY, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- Smile Scarsdale Family Dental is proud to celebrate its one-year anniversary of delivering exceptional family dental care to the Scarsdale community and surrounding areas. Since …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on June 1, 2025 - 17:12 GMT

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/...

Median DOR of 21.7 months with 80% of responders achieving a deep response (≥80% tumor shrinkage) Depth and durability translating to prolonged OS with median OS of 21.3 months and 2-year OS of 46% in HPV-negative HNSCC Conference call and webcast today at …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 14:45 GMT

Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated ...

Data Highlights Transformative Promise of CAR T in Solid Tumors Phase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC A Single Dose of ALLO-316 Achieved a 31% …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 14:00 GMT

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 ...

- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and were …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...